Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.

BACKGROUND The Post-Licensure Rapid Immunization Safety Monitoring (PRISM) program is the immunization safety monitoring component of FDA's Mini-Sentinel project, a program to actively monitor the safety of medical products using electronic health information. FDA sought to assess the surveillance capabilities of this large claims-based distributed database for vaccine safety surveillance by characterizing the underlying data. METHODS We characterized data available on vaccine exposures in PRISM, estimated how much additional data was gained by matching with select state and local immunization registries, and compared vaccination coverage estimates based on PRISM data with other available data sources. We generated rates of computerized codes representing potential health outcomes relevant to vaccine safety monitoring. Standardized algorithms including ICD-9 codes, number of codes required, exclusion criteria and location of the encounter were used to obtain the background rates. RESULTS The majority of the vaccines routinely administered to infants, children, adolescents and adults were well captured by claims data. Immunization registry data in up to seven states comprised between 5% and 9% of data for all vaccine categories with the exception of 10% for hepatitis B and 3% and 4% for rotavirus and zoster respectively. Vaccination coverage estimates based on PRISM's computerized data were similar to but lower than coverage estimates from the National Immunization Survey and Healthcare Effectiveness Data and Information Set. For the 25 health outcomes of interest studied, the rates of potential outcomes based on ICD-9 codes were generally higher than rates described in the literature, which are typically clinically confirmed cases. CONCLUSION PRISM program's data on vaccine exposures and health outcomes appear complete enough to support robust safety monitoring.

[1]  Matthew M Davis,et al.  Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States. , 2012, Archives of pediatrics & adolescent medicine.

[2]  L. Kurland,et al.  An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. , 1984, American journal of epidemiology.

[3]  C. Shih,et al.  Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan , 2012, Rheumatology International.

[4]  T. Lieu,et al.  Predictive value of seizure ICD-9 codes for vaccine safety research. , 2009, Vaccine.

[5]  E. Ben-Chetrit,et al.  Poliovaccines and the course of systemic lupus erythematosus--a retrospective study of 73 patients. , 1992, Vaccine.

[6]  Y. T. Lin,et al.  Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006 , 2010, Pediatrics international : official journal of the Japan Pediatric Society.

[7]  J A Bryan,et al.  Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. , 1979, American journal of epidemiology.

[8]  T. Lieu,et al.  Health outcomes of interest for evaluation in the Post-Licensure Rapid Immunization Safety Monitoring Program. , 2012, Vaccine.

[9]  J. Fratkin,et al.  An uncommon illness with a rare presentation: neurosurgical management of ADEM with tumefactive demyelination in children , 2010, Child's Nervous System.

[10]  Robert T. Chen,et al.  Guillain-Barré syndrome following influenza vaccination , 2004, Reactions Weekly.

[11]  S. Bernatsky,et al.  The Accuracy of Administrative Data Diagnoses of Systemic Autoimmune Rheumatic Diseases , 2011, The Journal of Rheumatology.

[12]  Marian F MacDorman,et al.  Fetal and perinatal mortality, United States, 2005. , 2009, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[13]  Robert T. Chen,et al.  Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. , 2004, The New England journal of medicine.

[14]  E. Belongia,et al.  Henoch-Schönlein Purpura and Polysaccharide Meningococcal Vaccine , 2010, Pediatrics.

[15]  Chiu Ym,et al.  Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. , 2010 .

[16]  Nicola P Klein,et al.  Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. , 2012, JAMA.

[17]  L. Akinbami,et al.  Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. , 2012, NCHS data brief.

[18]  E. Beghi,et al.  Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970–1981 , 1985, Annals of neurology.

[19]  W Katherine Yih,et al.  Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. , 2012, American journal of epidemiology.

[20]  W Katherine Yih,et al.  Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures , 2010, Pediatrics.

[21]  T. Southwood,et al.  Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins , 2002, The Lancet.

[22]  Yeong-hwang Chen,et al.  Bell's palsy associated with influenza vaccination: two case reports. , 2007, Vaccine.

[23]  Nick Andrews,et al.  Thimerosal Exposure in Infants and Developmental Disorders: A Retrospective Cohort Study in the United Kingdom Does Not Support a Causal Association , 2004, Pediatrics.

[24]  S. Gabriel,et al.  Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. , 2002, Arthritis and rheumatism.

[25]  S. Black,et al.  Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines , 2009, The Lancet.

[26]  R. Gray,et al.  Subfertility and risk of spontaneous abortion. , 2000, American journal of public health.

[27]  Hans Krueger,et al.  Validation of classification algorithms for childhood diabetes identified from administrative data , 2012, Pediatric diabetes.

[28]  W Katherine Yih,et al.  Real-Time Surveillance to Assess Risk of Intussusception and Other Adverse Events After Pentavalent, Bovine-Derived Rotavirus Vaccine , 2010, The Pediatric infectious disease journal.

[29]  Ross E. G. Upshur,et al.  Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. , 2006, Archives of internal medicine.

[30]  L. Kurland,et al.  Optic neuritis , 1995, Neurology.

[31]  Frederick W. Fraunfelder,et al.  Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports , 2010, Cutaneous and ocular toxicology.

[32]  M. Sawyer,et al.  Acute Disseminated Encephalomyelitis in Childhood: Epidemiologic, Clinical and Laboratory Features , 2004, The Pediatric infectious disease journal.

[33]  M. Houde,et al.  The incidence of juvenile rheumatoid arthritis in Quebec: a population data-based study , 2009, Pediatric rheumatology online journal.

[34]  Michael Nguyen,et al.  The Food and Drug Administration's Post‐Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise , 2012, Pharmacoepidemiology and drug safety.

[35]  Kevin M. White,et al.  Anaphylaxis from the Influenza Virus Vaccine , 2007, International Archives of Allergy and Immunology.

[36]  Heather A. Young,et al.  Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink , 2008, Journal of the Neurological Sciences.

[37]  G. Borm,et al.  Recurrence of febrile seizures in the respiratory season is associated with influenza A. , 2004, The Journal of pediatrics.

[38]  L. Horowitz.  Urticaria Subsequent to Administration of Influenza Vaccine , 1979, Southern medical journal.

[39]  S. Greene,et al.  Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. , 2012, Vaccine.

[40]  Robert T. Chen,et al.  A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)—United States, 1991–2001 , , 2004, Pharmacoepidemiology and drug safety.

[41]  M. Bruijnzeels,et al.  Incidence of febrile seizures in The Netherlands. , 1992, Neuroepidemiology.

[42]  E. Lewis,et al.  Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. , 2010, Vaccine.

[43]  Robert Ball,et al.  Adverse events reported following live, cold-adapted, intranasal influenza vaccine. , 2005, JAMA.

[44]  D. Gritz,et al.  Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. , 2004, Ophthalmology.

[45]  R. Davis,et al.  Risk of anaphylaxis after vaccination of children and adolescents. , 2003, Pediatrics.

[46]  M. Braun,et al.  Adverse Events After Inactivated Influenza Vaccination Among Children Less Than 2 Years of Age: Analysis of Reports From the Vaccine Adverse Event Reporting System, 1990–2003 , 2005, Pediatrics.

[47]  Ruihua Yin,et al.  Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. , 2010, American journal of epidemiology.

[48]  M. Nørgaard,et al.  Is the incidence of perimyocarditis increased following Campylobacter jejuni infection? , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[49]  Robert T. Chen,et al.  The incidence of Kawasaki syndrome in West Coast health maintenance organizations , 2000, The Pediatric infectious disease journal.

[50]  L. Morrison,et al.  Proposed diagnostic criteria and nosology of acute transverse myelitis , 2003 .

[51]  W Katherine Yih,et al.  Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance. , 2012, Health affairs.

[52]  Jeffrey N Katz,et al.  Validation of rheumatoid arthritis diagnoses in health care utilization data , 2011, Arthritis research & therapy.

[53]  L. Lix,et al.  Surveillance of systemic autoimmune rheumatic diseases using administrative data , 2011, Rheumatology International.

[54]  E. Beghi,et al.  Validity of hospital discharge diagnoses for public health surveillance of the Guillain-Barrè syndrome , 2002, Neurological Sciences.

[55]  J. Sejvar,et al.  Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. , 2007, Vaccine.

[56]  Josemir W Sander,et al.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. , 2000, Brain : a journal of neurology.

[57]  Ruihua Yin,et al.  H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. , 2011, American journal of preventive medicine.

[58]  H. Koga,et al.  Neurologic complications associated with influenza vaccination: two adult cases. , 2003, Internal medicine.

[59]  Robert L Davis,et al.  Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. , 2003, Pediatrics.

[60]  Stanley Xu,et al.  A Population-Based, Multisite Cohort Study of the Predictors of Chronic Idiopathic Thrombocytopenic Purpura in Children , 2008, Pediatrics.

[61]  P. Colombo,et al.  Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000–2002: a retrospective analysis , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[62]  Marsha A Raebel,et al.  Design considerations, architecture, and use of the Mini‐Sentinel distributed data system , 2012, Pharmacoepidemiology and drug safety.

[63]  E. Beghi,et al.  Prevalence of tic disorders among primary school students in the city of Pavia, Italy. , 2004, Archives of disease in childhood.

[64]  J. Iskander,et al.  Lack of Association Between Acellular Pertussis Vaccine and Seizures in Early Childhood , 2010, Pediatrics.

[65]  James Bates,et al.  Optic neuritis after influenza vaccination. , 1997, American journal of ophthalmology.

[66]  R. Holman,et al.  Kawasaki syndrome hospitalizations among children in Hawaii and Connecticut. , 2000, Archives of pediatrics & adolescent medicine.

[67]  Katherine J. Lee,et al.  Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. , 2011, Vaccine.

[68]  M. Partinen,et al.  Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland , 2012, PloS one.

[69]  Kai-Liang Kao,et al.  Myopericarditis Associated with Varicella Zoster Virus Infection , 2010, Pediatric Cardiology.

[70]  A. Qureshi,et al.  Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System. , 2007, Vaccine.

[71]  E. Mayer-Davis,et al.  The Many Faces of Diabetes in American Youth: Type 1 and Type 2 Diabetes in Five Race and Ethnic Populations: The SEARCH for Diabetes in Youth Study , 2009, Diabetes Care.

[72]  R. Devlieger,et al.  Brachial plexus neuritis following HPV vaccination. , 2008, Vaccine.

[73]  D. Gritz,et al.  Incidence and prevalence of uveitis in Northern California , 2004 .

[74]  P. Rothman,et al.  T-cell responses and hypersensitivity to influenza and egg antigens among adults with asthma immunized with the influenza vaccine. , 2003, The Journal of allergy and clinical immunology.

[75]  Jasvinder A Singh,et al.  Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis. , 2004, Arthritis and rheumatism.